reports
Gerresheimer AG: 1 director
A director at Gerresheimer AG bought 1,000 shares at 74.994EUR and the significance rating of the trade was 57/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearl...
EQS-News: Solar power for Gerresheimer site in Momignies, Belgium
EQS-News: Gerresheimer AG / Key word(s): ESG Solar power for Gerresheimer site in Momignies, Belgium 14.10.2024 / 11:00 CET/CEST The issuer is solely responsible for the content of this announcement. Solar power for Gerresheimer site in Momignies, Belgium 2.3 MWp rooftop photovoltaic system on production building Gerresheimer increases share of green electricity in its energy supply Goal for 2030: 100% electricity from renewable sources Duesseldorf/Momignies, October 14, 2024. Gerresheimer, an innovative system and solution partner and a global partner for the pharma, ...
EQS-News: Solarstrom für Gerresheimer Standort in Momignies, Belgien
EQS-News: Gerresheimer AG / Schlagwort(e): ESG Solarstrom für Gerresheimer Standort in Momignies, Belgien 14.10.2024 / 11:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Solarstrom für Gerresheimer Standort in Momignies, Belgien 2,3 MWp Photovoltaik-Dachanlage auf Produktionsgebäude Gerresheimer baut Ökostromanteil bei Energieversorgung aus Ziel bis 2030: 100 % Strom aus erneuerbaren Quellen Düsseldorf/ Momignies, 14. Oktober 2024. Gerresheimer, innovativer System- und Lösungsanbieter und globaler Partner für die Pharma-, Biotec...
- Oliver Metzger
- Thomas Zlowodzki
ODDO BHF Small & MIDCAP MORNING NEWS - 10/01/2024
Like Astérix in the album of the same name, Michel Barnier has a cauldron to fill. Two measures to manage this have “leaked” in the press in the last few days: a reduction in the CIR research tax credit and an exceptional tax increase on large companies. We measured the sensitivity to these two measures of the 90 and 80 companies most concerned in our coverage universe. 20 companies have a CIR >5% of their EBIT and 22 companies would see their EPS fall by more than 5% due to the addit...
- Oliver Metzger
- Thomas Zlowodzki
ODDO BHF Small & MIDCAP MORNING NEWS - 01/10/2024
Comme Astérix dans l’album éponyme, Barnier a un chaudron à remplir. Deux mesures pour y parvenir ont « fuité » ces derniers jours dans la presse : rabotage du CIR (Crédit d’impôt Recherche) et hausse « exceptionnelle » de l’impôt des sociétés sur les grands groupes. Nous avons mesuré la sensibilité des 90 et 80 sociétés les plus concernées dans notre univers de couverture à ces deux mesures. 20 sociétés ont un CIR > 5% de leur EBIT et 22 sociétés verraient leurs BPA baisser de plus d...
- Oliver Metzger
Gerresheimer AG : Not only 2024, but also 2025
>Cut to ambitious 2024 outlook…. - Gerresheimer announced the reduction of its 2024 guidance to 3-4% organic growth now (from 5% to 10% before) due to a significantly slower-than-expected market recovery. The guidance is also affected by the current flooding at the Morganton vial plant in the United States caused by Hurricane Helene, which will halt production for several weeks. We acknowledge that our Q3 organic growth forecast of 3.3% would have implied a strong acc...
EQS-News: Gerresheimer, Stevanato Group and SCHOTT Pharma Announce Str...
EQS-News: Gerresheimer AG / Key word(s): Alliance Gerresheimer, Stevanato Group and SCHOTT Pharma Announce Strategic Industry “Alliance for RTU” 26.09.2024 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. Gerresheimer, Stevanato Group and SCHOTT Pharma Announce Strategic Industry “Alliance for RTU” Market advances adoption of ready-to-use containers Improved operational efficiency in pharmaceutical manufacturing processes Increased patient safety with high-quality sterile primary packaging Düsseldorf, September 26, 2024. Gerreshe...
EQS-News: Gerresheimer, Stevanato Group und SCHOTT Pharma schließen st...
EQS-News: Gerresheimer AG / Schlagwort(e): Kooperation Gerresheimer, Stevanato Group und SCHOTT Pharma schließen strategische 'Alliance for RTU' 26.09.2024 / 12:30 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Gerresheimer, Stevanato Group und SCHOTT Pharma schließen strategische "Alliance for RTU" Marktakzeptanz von „Ready-to-Use“-Primärverpackungen schreitet voran Verbesserung der Betriebseffizienz in pharmazeutischen Herstellungsprozessen Erhöhung der Patientensicherheit durch hochwertige sterile Primärverpackungen Düsseldorf...
EQS-News: Gerresheimer: EcoVadis Gold mit erneut verbesserter Punktzah...
EQS-News: Gerresheimer AG / Schlagwort(e): ESG Gerresheimer: EcoVadis Gold mit erneut verbesserter Punktzahl 16.09.2024 / 13:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Gerresheimer: EcoVadis Gold mit erneut verbesserter Punktzahl Gerresheimer unter den Top 3 % aller bewerteten Unternehmen Gesamtergebnis auf 76/100 Punkten gesteigert Auszeichnung unterstreicht konsequente Umsetzung der Nachhaltigkeitsstrategie Düsseldorf, 16. September 2024. Gerresheimer, innovativer System- und Lösungsanbieter und globaler Partner für die P...
EQS-News: Gerresheimer: EcoVadis Gold with further improved score
EQS-News: Gerresheimer AG / Key word(s): ESG Gerresheimer: EcoVadis Gold with further improved score 16.09.2024 / 13:00 CET/CEST The issuer is solely responsible for the content of this announcement. Gerresheimer: EcoVadis Gold with further improved score Gerresheimer among the top 3 % of all rated companies Overall result increased to 76/100 points Award underlines consistent implementation of the sustainability strategy Düsseldorf, September 16, 2024 - Gerresheimer, an innovative systems and solutions provider and global partner for the pharma, biotech and cosmetics ...
- Thomas J. Schiessle
Q2/24 - Destocking at Standard Vails not yet over - FY 24 guidance sha...
Q2/24 was slightly below expectations; the destocking at Standard Vails was and is proceeding more hesitantly, so that the CFO in 11.07.24 is now aiming for the FY 24 topline plus (FX-neutral sales: +5-10% YoY) “at the lower end” of the range. The intra-year phasing remains (H2/24 > H1/24; better product mix, margins) so that the FY 24 guidance (as well as for FY 25 and mid-term ambitions) was confirmed
- Thomas J. Schiessle
Q2/24 - Destocking bei Standard Vails noch nicht beendet - 24er Guidan...
Das Q2/24 war etwas unter den Erwartungen; das Destocking bei Standard-Vails verlief und verläuft zögerlicher, so dass der CFO im 11.07.24 das FY 24-Topline-Plus (FX-neutraler Umsatz: +5-10 % YoY) jetzt „am unteren Ende“ der Spanne anstrebt. Das unterjährige Phasing bleibt (H2/24 > H1/24; besserer Produktmix, Margen) so dass die Guidance FY 24 (wie auch für FY 25 und Mittelfrist-Ambitionen) bestätigt wurde.
- Oliver Metzger
- Oliver Metzger
- Oliver Metzger
Gerresheimer AG : Destocking to come to an end, lower end of guidance ...
>Primary Packaging Glass – Destocking to end in H2 - Destocking at glass vials started in Q3 2023 and has had a stronger impact than previously assumed. While the company described the initial destocking as already phased out, management acknowledged that destocking has been expanded towards some other areas on the back of working capital considerations of customers. However, Gerresheimer is confident that despite the fact that destocking takes a little bit longer, it...
- Oliver Metzger
- Oliver Metzger
- Oliver Metzger
Gerresheimer AG : Q2 review – better on bottom line and guidance confi...
>Top line impacted by destocking in Primary Packaging Glass - The company reported Q2 2024 revenues of € 502.4m (+0.6% y-o-y, 1%/-1% vs ODDO BHF/consensus). Organic growth was 0.7% compared to our estimate of 0.8%. Forex headwinds amounted to 10bp.Primary Packaging Glass declined organically by 6.9% (revenues € 218.1m, in line with expectations) in the quarter on the back of destocking. On the other hand, cosmetics were up again.Plastics & devices was up by ...
EQS-News: Gerresheimer bleibt im 1. Halbjahr 2024 auf Kurs
EQS-News: Gerresheimer AG / Schlagwort(e): Halbjahresergebnis Gerresheimer bleibt im 1. Halbjahr 2024 auf Kurs 11.07.2024 / 07:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Gerresheimer bleibt im 1. Halbjahr 2024 auf Kurs Organisches Wachstum: Umsatz +1,7 %, Adjusted EBITDA +2,9 % Geschäftsbereich Plastics & Devices mit gutem Umsatzwachstum und deutlich verbesserter Marge Prognose bestätigt Düsseldorf, 11. Juli 2024. Gerresheimer, innovativer System- und Lösungsanbieter und globaler Partner für die Pharma-, Biotech- und Kosmet...
EQS-News: Gerresheimer remains on track in 1st half year 2024
EQS-News: Gerresheimer AG / Key word(s): Half Year Results Gerresheimer remains on track in 1st half year 2024 11.07.2024 / 07:00 CET/CEST The issuer is solely responsible for the content of this announcement. Gerresheimer remains on track in 1st half year 2024 Organic growth: revenues +1.7%, adjusted EBITDA +2.9% Plastics & Devices division with good revenue growth and significantly improved margin Guidance confirmed Düsseldorf (Germany), July 11, 2024. Gerresheimer, an innovative systems & solutions provider and global partner for the pharma, biotech and cosmetic ind...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.